CCC

JSE:CCC South Africa Drug Manufacturers - Specialty & Generic
Market Cap
$2.41 Billion
R45.86 Billion ZAR
Market Cap Rank
#24514 Global
#29 in South Africa
Share Price
R199.00
Change (1 day)
+0.00%
52-Week Range
R150.00 - R217.00
All Time High
R217.00
About

Cilo Cybin Holdings Limited cultivates, manufactures, and sells medical cannabis products worldwide. The company offers CBD, THC, and THCV distillates; THC and CBD crude; CBD, CBG, and CBN isolates; CBD Nano Oil; oil in bottles, cannabis flower, and cannabis vapes; and topicals, capsules, and device products. It also provides flower sourcing, formulation, manufacturing, and primary and secondary … Read more

CCC (CCC) - Total Assets

Latest total assets as of September 2025: R108.94 Million ZAR

Based on the latest financial reports, CCC (CCC) holds total assets worth R108.94 Million ZAR as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

CCC - Total Assets Trend (2022–2025)

This chart illustrates how CCC’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

CCC - Asset Composition Analysis

Current Asset Composition (March 2025)

CCC's total assets of R108.94 Million consist of 94.1% current assets and 6.0% non-current assets.

Asset Category Amount (ZAR) % of Total Assets
Cash & Equivalents R0.00 92.9%
Accounts Receivable R716.10K 1.1%
Inventory R0.00 0.0%
Property, Plant & Equipment R0.00 0.0%
Intangible Assets R0.00 0.0%
Goodwill R0.00 0.0%

Asset Composition Trend (2022–2025)

This chart illustrates how CCC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: CCC's current assets represent 94.1% of total assets in 2025, a decrease from 100.0% in 2022.
  • Cash Position: Cash and equivalents constituted 92.9% of total assets in 2025, down from 100.0% in 2022.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
  • Asset Diversification: The largest asset category is accounts receivable at 1.1% of total assets.

CCC Competitors by Total Assets

Key competitors of CCC based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

CCC - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.00 - 0.00

Lower asset utilization - CCC generates 0.00x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -714.66% - 0.72%

Negative ROA - CCC is currently not profitable relative to its asset base.

CCC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 18.49 77.48 0.14
Quick Ratio 14.84 77.48 0.14
Cash Ratio 0.00 0.00 0.00
Working Capital R85.21 Million R 59.88 Million R -266.00K

CCC - Advanced Valuation Insights

This section examines the relationship between CCC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 4.69
Latest Market Cap to Assets Ratio 0.39
Asset Growth Rate (YoY) -0.8%
Total Assets R62.77 Million
Market Capitalization $24.72 Million USD

Valuation Analysis

Below Book Valuation: The market values CCC's assets below their book value (0.39 x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: CCC's assets decreased by 0.8% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for CCC (2022–2025)

The table below shows the annual total assets of CCC from 2022 to 2025.

Year Total Assets Change
2025-03-31 R62.77 Million -0.80%
2024-03-31 R63.28 Million +81821.97%
2023-03-31 R77.24K +672.39%
2022-03-31 R10.00K --